Literature DB >> 10942596

Determinants of NPC1 expression and action: key promoter regions, posttranscriptional control, and the importance of a "cysteine-rich" loop.

H Watari1, E J Blanchette-Mackie, N K Dwyer, M Watari, C G Burd, S Patel, P G Pentchev, J F Strauss.   

Abstract

Mutations in the NPC1 gene cause Niemann-Pick type C disease, which is characterized by the accumulation of free cholesterol and other lipids in lysosomes. The NPC1 glycoprotein is located in a late endosomal compartment that transiently interacts with lysosomes. To identify factors regulating NPC1 expression and action, we analyzed the function of the human NPC1 promoter in human-derived ovarian, hepatic, and neuronal cells. A fragment containing the first 208 base pairs upstream from the major transcription initiation site was sufficient to drive near maximal NPC1 promoter activity. Deletion analysis revealed that sequences between base pairs -111 and -37 play an important role in controlling NPC1 transcription. Treatment of proliferating granulosa cells with 30 microM progesterone, which induces a reversible phenocopy of the cholesterol trafficking defect of Niemann-Pick type C disease, increased NPC1 mRNA levels threefold. The protein synthesis inhibitor, cycloheximide, also increased NPC1 mRNA levels, augmenting the progesterone-induced increase in NPC1 mRNA abundance. Progesterone treatment was shown to increase the mRNA half-life, but did not affect NPC1 promoter activity. Cysteine residues in a "cysteine-rich" loop predicted to reside in the intralumenal compartment of vesicles containing NPC1 were mutated, resulting in proteins that were incapable of correcting the cholesterol trafficking defect in CT60 cells, a Chinese hamster cell line in which the endogenous NPC1 gene is inactivated. Converting isoleucine 1061, also predicted to lie within the cysteine-rich loop, to a threonine residue inactivated the protein as well. The I1061T mutation is one of the most common mutations in Niemann-Pick type C disease. All of the cysteine-rich loop mutants were localized to cholesterol-engorged lysosomes in a pattern mimicking the distribution of NPC1 in progesterone-treated cells. A recombinant protein representing the cysteine-rich loop was shown to bind to a zinc-NTA agarose column. We conclude: (1) that cis elements residing in the first 111 base pairs upstream from the transcription start site are critical for transcription of the NPC1 gene; (2) that NPC1 expression is subject to posttranscriptional regulation in response to treatments that disrupt NPC1 function; and (3) that an intralumenal cysteine-rich loop with zinc-binding activity is critical to NPC1's ability to unload lysosomal cargo. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942596     DOI: 10.1006/excr.2000.4976

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

1.  Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop.

Authors:  G Millat; C Marçais; C Tomasetto; K Chikh; A H Fensom; K Harzer; D A Wenger; K Ohno; M T Vanier
Journal:  Am J Hum Genet       Date:  2001-05-01       Impact factor: 11.025

2.  Prospective Turkish Cohort Study to Investigate the Frequency of Niemann-Pick Disease Type C Mutations in Consanguineous Families with at Least One Homozygous Family Member.

Authors:  Meral Topçu; Dilek Aktas; Merih Öztoprak; Neslihan Önenli Mungan; Aysel Yuce; Mehmet Alikasifoglu
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

3.  Phenotypic heterogeneity of Niemann-Pick disease type C in monozygotic twins.

Authors:  Alberto Benussi; Antonella Alberici; Enrico Premi; Valeria Bertasi; Maria Sofia Cotelli; Marinella Turla; Andrea Dardis; Stefania Zampieri; Eleonora Marchina; Barbara Paghera; Francesca Gallivanone; Isabella Castiglioni; Alessandro Padovani; Barbara Borroni
Journal:  J Neurol       Date:  2014-12-24       Impact factor: 4.849

4.  Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts.

Authors:  Nina H Pipalia; Casey C Cosner; Amy Huang; Anamitra Chatterjee; Pauline Bourbon; Nathan Farley; Paul Helquist; Olaf Wiest; Frederick R Maxfield
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

5.  Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1.

Authors:  X Sun; D L Marks; W D Park; C L Wheatley; V Puri; J F O'Brien; D L Kraft; P A Lundquist; M C Patterson; R E Pagano; K Snow
Journal:  Am J Hum Genet       Date:  2001-05-09       Impact factor: 11.025

Review 6.  Expression profiling of human breast cancers and gene regulation by progesterone receptors.

Authors:  Britta M Jacobsen; Jennifer K Richer; Carol A Sartorius; Kathryn B Horwitz
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

7.  The Niemann-Pick C1 gene is downregulated by feedback inhibition of the SREBP pathway in human fibroblasts.

Authors:  William S Garver; David Jelinek; Gordon A Francis; Bruce D Murphy
Journal:  J Lipid Res       Date:  2008-02-13       Impact factor: 5.922

8.  Niemann-Pick type C1 I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding.

Authors:  Mark E Gelsthorpe; Nikola Baumann; Elizabeth Millard; Sarah E Gale; S Joshua Langmade; Jean E Schaffer; Daniel S Ory
Journal:  J Biol Chem       Date:  2008-01-23       Impact factor: 5.157

9.  The National Niemann-Pick Type C1 Disease Database: correlation of lipid profiles, mutations, and biochemical phenotypes.

Authors:  William S Garver; David Jelinek; F John Meaney; James Flynn; Kathleen M Pettit; Glen Shepherd; Randall A Heidenreich; Cate M Walsh Vockley; Graciela Castro; Gordon A Francis
Journal:  J Lipid Res       Date:  2009-09-09       Impact factor: 5.922

10.  Novel NPC1 mutations with different segregation in two related Greek patients with Niemann-Pick type C disease: molecular study in the extended pedigree and clinical correlations.

Authors:  Evangelia Bountouvi; Anna Papadopoulou; Marie T Vanier; Georgia Nyktari; Spyridon Kanellakis; Helen Michelakakis; Argyrios Dinopoulos
Journal:  BMC Med Genet       Date:  2017-05-04       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.